Telecommunications, Trade & Consumer Electronics News

Our Publications

Communications Daily
Communications Litigation Today
Export Compliance Daily
International Trade Today
Trade Law Daily

Our Papers

2022 Sanctions and Export Enforcement Recap
2023 U.S. Harmonized Tariff Schedule Guide
Special Report on Robocall Scourge
2022 U.S. Harmonized Tariff Schedule Guide
Summary of Commerce's AD/CVD Final Rule
Harmonized Tariff Schedule July 2021 Summary
2020 CBP Rulings and Revocations Summary
2021 U.S. Harmonized Tariff Schedule Guide
Special Report on Communications Diversity
Harmonized Tariff Schedule July 2020 Summary
2019 CBP Rulings and Revocations Summary
2020 U.S. Harmonized Tariff Schedule Guide
2019 Sanctions and Export Enforcement Recap
Harmonized Tariff Schedule July 2019 Summary
Special Report on Emergency Communications
2019 U.S. Harmonized Tariff Schedule Guide
2018 CBP Rulings and Revocations Summary
Medical Devices Classification Guide
Footwear Classification Guide
Harmonized Tariff Schedule July 2018 Summary
Pharmaceuticals Tariff Classification Guide
Drug and Device Customs Rulings Summary Q1 2018
2017 CBP Rulings and Revocations Summary
2018 U.S. Harmonized Tariff Schedule Guide
The Pai Perspective
Harmonized Tariff Schedule July 2017 Summary
FDA Foreign Supplier Verification Program Guide
2016 CBP Rulings and Revocations Summary
2017 U.S. Harmonized Tariff Schedule Guide
The Course of Net Neutrality
WCO Harmonized System 2017 Update Guide
Information Technology Agreement Tariff Guide
Customs Reauthorization Compliance Guide

Drug and Device Customs Rulings Summary Q1 2018

Life Sciences Trade Alert’s Drug and Device Customs Rulings Summary is now available as a FREE resource for trade compliance professionals in the healthcare sector! Get all of CBP’s prospective rulings affect the pharmaceutical, medical device and biotechnology sectors in one convenient report. This two-part summary includes coverage of the first quarter of 2018, as well as a list of rulings issued by CBP’s National Commodity Specialist Division detailing the products subjected to ruling requests and CBP’s decision on their tariff classification.

Part One outlines rulings made by CBP Headquarters regarding classifications, declarations and country of origin. Ruling summaries that affect healthcare include drugs in clinical trials, prices paid by manufacturers and middlemen and more.

Part Two includes a list of CBP New York Ruling Summaries addressing:

✓
Hormonal Implants
✓
Prebiotic Fiber Feed Additives
✓
Portable Incubators
✓
Amitriptyline Hydrochloride
✓
And 31 more healthcare products.

 

Order Now!

To order your complimentary copy of the Drug and Device Customs Ruling Summary today, fill out the form below or contact your account representative at +1-800-771-9202.